Streamlined Method For Exempting CAP Drugs From ASP Urged By PhRMA, BIO
Executive Summary
CMS' planned method for exempting drug product sales to competitive acquisition program vendors from calculations of Part B average sales price should be revised to reduce data reporting between manufacturers and vendors, manufacturer groups recommend